HNN3.0
Register
Register
Register

Project cooperationUpdated on 16 October 2026

Molecular Diagnostics and qPCR Laboratory Partner for Horizon Europe Health 2027 Projects

Director at BIOMED LAB

Ohrid, North Macedonia

About

BIOMED LAB – Molecular Diagnostics and Laboratory Cooperation

BIOMED LAB is a private molecular diagnostics laboratory established in 2012 and located in Ohrid, North Macedonia.

The laboratory is seeking opportunities to join Horizon Europe Health 2027 research and innovation consortia as a molecular diagnostics, laboratory testing, assay verification or implementation partner.

Existing laboratory capabilities:

  • DNA and RNA extraction

  • Real-time PCR (qPCR) testing

  • Molecular laboratory workflows and sample processing

  • Laboratory quality documentation and method verification activities

Areas of interest for cooperation:

  • Development and evaluation of molecular diagnostic assays

  • qPCR-based biomarkers and infectious disease diagnostics

  • Personalised medicine and pharmacogenomics

  • Point-of-care molecular diagnostic technologies

  • Laboratory evaluation of innovative diagnostic platforms

  • Reproductive genetics and emerging genomic technologies

  • Integration of molecular diagnostics into clinical research

Potential contribution to European projects:

BIOMED LAB can contribute to laboratory feasibility assessments, molecular testing, assay verification, technical documentation and implementation activities within its available capabilities.

Where appropriate, the laboratory can explore cooperation with external clinical partners for sample recruitment and clinical evaluation, subject to applicable ethical and regulatory requirements.

Partnership sought:

We welcome collaboration with universities, research institutions, biotechnology companies, diagnostic developers, hospitals and Horizon Europe project coordinators.

Our preferred role is as a consortium partner contributing specialised molecular laboratory expertise rather than coordinating an entire Horizon Europe project.

Topic

  • Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
  • Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

Type

  • Partner seeks Consortium/Coordinator

Organisation

BIOMED LAB

Company (SME)

Ohrid, North Macedonia

Similar opportunities